NEA 16 Gp, LLC, 10% Owner at Trevi Therapeutics, Inc. (TRVI), bought 5,263,156 shares at $1.90 ($10.0M) on 2022-04-11, disclosed to the SEC on 2022-04-13.
Open-market purchase of $10.0M TRVI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.90 | 2,631,578 | $5.0M | 50.0% |
| 2 | $1.90 | 2,631,578 | $5.0M | 50.0% |
| Total | $1.90 avg | 5,263,156 | $10.0M | 100% |
| Filing → |
| TRVI | BUY | 2019-05-13 | $25.0M | — | Filing → |